What's New
| Page summary | Text size | Search | |
What’s New keeps you up-to-date with the latest InCirculation.net activities.
| | |
10 August 2010RE-LY showed conclusively that treatment with dabigatran significantly reduces stroke risk in comparison with warfarin in patients with atrial fibrillation and at least one risk factor. John Camm presents the data and discusses the implications of this landmark study.
11 November 2009Until recently, the role of exercise therapy in heart failure had only been studied with small, inconclusive trials. In this article, Sidney Goldstein discusses the importance of HF-ACTION, the first randomized trial to examine the benefits and risks of exercise as a therapeutic modality for heart failure with an adequate sample size. 28 April 2009The accurate diagnosis of acute myocardial infarction (AMI) is crucial for therapy, clinical trials and population research. But the diagnosis is in flux as new and more sensitive diagnostic measures become widely available and the presentation of AMI in hospital changes. Russell Luepker discusses these shifts and recent recommendations for the diagnosis of AMI by authoritative bodies.
| |
